These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 8481594)
1. New bisphosphonates in osteoporosis. Fleisch H Osteoporos Int; 1993; 3 Suppl 2():S15-22. PubMed ID: 8481594 [TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates: preclinical aspects and use in osteoporosis. Fleisch HA Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324 [TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates in osteoporosis: an introduction. Fleisch H Osteoporos Int; 1993; 3 Suppl 3():S3-5. PubMed ID: 8298201 [TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates in the treatment of osteoporosis. Bell NH; Johnson RH Endocrine; 1997 Apr; 6(2):203-6. PubMed ID: 9225137 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of action of the bisphosphonates. Fleisch H Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates: from the laboratory to the clinic and back again. Russell RG; Rogers MJ Bone; 1999 Jul; 25(1):97-106. PubMed ID: 10423031 [TBL] [Abstract][Full Text] [Related]
7. Rationale for the use of clodronate in osteoporosis. Kanis JA; McCloskey EV; Sirtori P; Khan S; Fern D; Eyres K; Aaron J; Beneton MN Osteoporos Int; 1993; 3 Suppl 2():S23-8. PubMed ID: 8481595 [TBL] [Abstract][Full Text] [Related]
8. Clinical trials with bisphosphonates. Lombardi A; Santora AC Ann Ital Med Int; 1992; 7(3 Suppl):158S-165S. PubMed ID: 1297394 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Fleisch H Drugs; 1991 Dec; 42(6):919-44. PubMed ID: 1724640 [TBL] [Abstract][Full Text] [Related]
10. Rationale for the use of alendronate in osteoporosis. Kanis JA; Gertz BJ; Singer F; Ortolani S Osteoporos Int; 1995 Jan; 5(1):1-13. PubMed ID: 7703618 [TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates: the first 40 years. Russell RG Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003 [TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate therapy. Licata AA Am J Med Sci; 1997 Jan; 313(1):17-22. PubMed ID: 9001162 [TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates in the treatment of disorders of mineral metabolism. Singer FR; Minoofar PN Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099 [TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates in the treatment of metabolic bone diseases. Rodan GA; Balena R Ann Med; 1993 Aug; 25(4):373-8. PubMed ID: 8217103 [TBL] [Abstract][Full Text] [Related]
15. Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis. McClung MR Bone; 1996 Nov; 19(5 Suppl):195S-198S. PubMed ID: 8922662 [TBL] [Abstract][Full Text] [Related]
16. New bisphosphonates in the treatment of bone diseases. Gatti D; Adami S Drugs Aging; 1999 Oct; 15(4):285-96. PubMed ID: 10582775 [TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update. Fleisch H Horm Metab Res; 1997 Mar; 29(3):145-50. PubMed ID: 9137986 [TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism. Fleisch H Recent Results Cancer Res; 1989; 116():1-28. PubMed ID: 2669065 [TBL] [Abstract][Full Text] [Related]
19. Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Fitton A; McTavish D Drugs; 1991 Feb; 41(2):289-318. PubMed ID: 1709854 [TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates in bone diseases. Sparidans RW; Twiss IM; Talbot S Pharm World Sci; 1998 Oct; 20(5):206-13. PubMed ID: 9820883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]